• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | Registration & Listing | Adverse Events | Recalls | PMA | Classification | Standards | Inspections
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
Note: this medical device has supplements. The device description may have changed. Be sure to look at the supplements to get an up-to-date view of this device.
 
Trade NameBIODIVYSIO AS PS (PHOSPHORYLCHOLINE)COATED STENT DELIVERY SYSTEM
Classification Namestent, coronary
Generic Nameintravascular coronary stent
ApplicantABBOTT VASCULAR INC.
PMA NumberP000011
Date Received02/25/2000
Decision Date09/29/2000
Product Code
MAF[ Registered Establishments with MAF ]
Docket Number 01M-0055
Notice Date 03/09/2001
Advisory Committee Cardiovascular
Expedited Review Granted? No
Combination Product No
Information About: Labeling, Approval Order, Summary of Safety and Effectiveness
Approval Order Statement 
Approval for the biodivysio(tm) as pc (phosphorylcholine) coated stent and delivery system. The device is intended for use in subjects with symptomatic ischemic heart disease due to de novo native coronary artery lesions (length <= 25 mm) with a reference vessel diameter ranging from >= 3. 0 mm to <= 4. 0 mm and intended to improve coronary luminal diameter. Long term outcome (beyond six months) for this permanent implant is unknown at present.
Approval Order Approval Order
Supplements: S001 S002 S003 S004 S005 S006 S007 S009 S010 
-
-